RESULTS AND DISCUSSIONS
Situations where the fair value cannot be reliably measured It is assumed that the fair value cannot be reliably measured for a biological asset. This hypothesis can be ignored only at the initial recognition of a biological asset, for which there are not available prices or values determined on the market and for which the alternative estimations of the fair value are not clearly reliable. In these cases, the biological assets will be evaluated at cost less any cumulated depreciation and any loss from cumulated depreciation. Once the fair value for such a biological asset can be measured reliably, an entity will measure it at the fair value less the estimated point-of-sale costs. When an asset meets the classification conditions as detained for sale according to IFRS 5, it is assumed that the fair value can be reliably measured. In all cases, an entity measures the agriculture products at the date of harvest at the fair value less the estimated at point-of-sale costs, reflecting in this way the idea that the agriculture products measured at the date of harvest can be always measured reliably. A government unconditional grant is relation to an measured
biological asset at the fair value less the estimated point-of-sale costs will be recognized as income when and only when the government grant becomes debt.